News

Equity research WPTG Q3 2026: Integration phase sets up for improved cash flow
12 Nov 2026
Equity research WPTG Q3 2026: Integration phase sets up for improved cash flow
Equity Research White Pearl Technology Group
Analys Elicera Therapeutics: Stärkta fas I-data för flaggskeppsprojekt
11 Nov 2026
Analys Elicera Therapeutics: Stärkta fas I-data för flaggskeppsprojekt
Equity Research Elicera Therapeutics
Analys Nodebis kv3 2026: Lönsamheten tar fart när OSS växlar upp
10 Nov 2026
Analys Nodebis kv3 2026: Lönsamheten tar fart när OSS växlar upp
Equity Research Nodebis
Equity Research Sveafastigheter, Q3 2026: Higher costs now, lower costs later on
09 Nov 2026
Equity Research Sveafastigheter, Q3 2026: Higher costs now, lower costs later on
Equity Research Sveafastigheter
Equity Research Sveafastigheter: Synergies should increase earnings capacity
27 Okt 2026
Equity Research Sveafastigheter: Synergies should increase earnings capacity
Equity Research Sveafastigheter
Equity Research ALM Equity, Q3 2026: Profit boost delayed despite higher construction activity
26 Okt 2026
Equity Research ALM Equity, Q3 2026: Profit boost delayed despite higher construction activity
Equity Research ALM Equity
Equity research CDON Q3 2026: Strong GMV momentum and Fyndiq relief
23 Okt 2026
Equity research CDON Q3 2026: Strong GMV momentum and Fyndiq relief
Equity Research CDON
Equity research CDON Q3 2026: First impression - Better growth than expected
22 Okt 2026
Equity research CDON Q3 2026: First impression - Better growth than expected
Equity Research CDON
Equity Research ALM Equity, Q3 2026: Pre-tax profit in line with expectations, despite low revenues
22 Okt 2026
Equity Research ALM Equity, Q3 2026: Pre-tax profit in line with expectations, despite low revenues
Equity Research ALM Equity
Equity research Zinzino Q3 2026: Preview - Higher profitability amid slight growth moderation
21 Okt 2026
Equity research Zinzino Q3 2026: Preview - Higher profitability amid slight growth moderation
Equity Research Zinzino
Equity Research ALM Equity, Q3 2026: Several development projects were started during the quarter
12 Okt 2026
Equity Research ALM Equity, Q3 2026: Several development projects were started during the quarter
Equity Research ALM Equity
Equity research CDON: Preview Q3 2026 - Fyndiq in focus
08 Okt 2026
Equity research CDON: Preview Q3 2026 - Fyndiq in focus
Equity Research CDON
Equity research Pila Pharma: XEN-D0501 returns to the clinic, with higher exposure now in focus
29 Sep 2026
Equity research Pila Pharma: XEN-D0501 returns to the clinic, with higher exposure now in focus
Equity Research Pila Pharma
Equity research, Immunovia: Announced rights issue and pause of coverage
29 Sep 2026
Equity research, Immunovia: Announced rights issue and pause of coverage
Equity Research Immunovia
Equity research, WPTG: Large AI infrastructure order boosts sales outlook
16 Sep 2026
Equity research, WPTG: Large AI infrastructure order boosts sales outlook
Equity Research White Pearl Technology Group
Equity research Pila Pharma H1 2026: From rat detour to clinical heat
28 Aug 2026
Equity research Pila Pharma H1 2026: From rat detour to clinical heat
Equity Research Pila Pharma
Equity research Zinzino Q2 2026: Strong profitability trend
26 Aug 2026
Equity research Zinzino Q2 2026: Strong profitability trend
Equity Research Zinzino
Equity research WPTG, Q2 2026: AI pivot accelerates growth and margins
26 Aug 2026
Equity research WPTG, Q2 2026: AI pivot accelerates growth and margins
Equity Research White Pearl Technology Group
Equity research Zinzino Q2 2026: First impression - ZZ tops estimates, maintains outlook
25 Aug 2026
Equity research Zinzino Q2 2026: First impression - ZZ tops estimates, maintains outlook
Equity Research Zinzino
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
21 Aug 2026
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
Equity Research Viva Wine Group